How would a drug that competes with ACh for receptors at the motor end plate affect skeletal muscle? It would:
**Core Concept**
The question is testing the understanding of the pharmacological effects of a drug that competes with acetylcholine (ACh) for receptors at the motor end plate. This is a classic example of competitive antagonism, where the drug binds to the same receptor as the endogenous neurotransmitter, reducing its efficacy.
**Why the Correct Answer is Right**
When a drug competes with ACh for receptors at the motor end plate, it reduces the amount of ACh that can bind to its receptors. This decrease in ACh receptor activation leads to a reduction in the release of calcium ions into the muscle cell, which in turn reduces the contraction of the skeletal muscle. This is because ACh binding to its receptors triggers a cascade of events that ultimately leads to muscle contraction.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because a drug that competes with ACh for receptors would not increase ACh release or cause an increase in muscle contraction.
**Option B:** This option is incorrect because a drug that competes with ACh for receptors at the motor end plate would not have a direct effect on the neuromuscular junction, but rather would reduce the efficacy of ACh transmission.
**Option C:** This option is incorrect because a drug that competes with ACh for receptors would not cause muscle paralysis or flaccidity, but rather would reduce muscle contraction.
**Option D:** This option is incorrect because a drug that competes with ACh for receptors would not cause muscle atrophy or denervation, but rather would reduce muscle contraction.
**Clinical Pearl / High-Yield Fact**
A classic example of a drug that competes with ACh for receptors at the motor end plate is succinylcholine, a neuromuscular blocking agent used in anesthesia. Succinylcholine competes with ACh for receptors at the motor end plate, leading to muscle paralysis and relaxation.
**Correct Answer:** C.